Shin‐ichiro Hamano

Author

Shin‐ichiro Hamano

Also Known As

S Hamano, S. Hamano, S.‐I. Hamano, SHIN‐ICHIRO HAMANO, Shin-Ichiro Hamano, Shin-ichiro Hamano, Shinichiro Hamano, Shin‐Ichiro Hamano, Shin‐ichiro Hamano, Shizuka Hamano

160

Publications

2.1K

Citations

H-Index

104

Concepts

All Affiliations

Saitama Children's Medical Center Jikei University School of Medicine National Center of Neurology and Psychiatry National Center For Child Health and Development Tokyo Women's Medical University

About

Shin‐ichiro Hamano is an author at Saitama Children's Medical Center specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	34	871
2	Social Sciences	7	7	173
3	Health Sciences	6	6	153
4	Education	1	1	23
5	Public Health	1	1	34

Shin‐ichiro Hamano

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy Takashi Sugawara, Emi Mazaki-Miyazaki, Katsuyuki Fukushima, Neurology	2002	236
<i>PIGA</i> mutations cause early-onset epileptic encephalopathies and distinctive features Mitsuhiro Kato, Hirotomo Saitsu, Yoshiko Murakami, Neurology	2014	103
Novel mutations in <i>Myoclonin1/EFHC1</i> in sporadic and familial juvenile myoclonic epilepsy Marco T. Medina, Toshimitsu Suzuki, María Elisa Alonso, Neurology	2008	77
A nationwide survey of pediatric acquired demyelinating syndromes in Japan Yuko Yamaguchi, Hiroyuki Torisu, Ryutaro Kira, Neurology	2016	75
Neurological manifestations of hemorrhagic colitis in the outbreak of <i>Escherichia coli</i> O157:H7 infection in Japan Shin‐ichiro Hamano, Youko Nakanishi, Takahiro Nara, Acta Paediatrica Microbial DiseaseHealth SciencesPathogen DetectionH7 InfectionMedicine	1993	58
Rituximab ameliorates anti-N-methyl-d-aspartate receptor encephalitis by removal of short-lived plasmablasts Yasuo Hachiya, Akinori Uruha, Emi Kasai‐Yoshida, Journal of Neuroimmunology Autoimmune DiseaseMedicineImmunologyPharmacologyPathology	2013	55
Predictive score for early diagnosis of acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) Hiroko Tada, Jun‐ichi Takanashi, Hideo Okuno, Journal of the Neurological Sciences Early DiagnosisNeuroimaging BiomarkersNeuropsychologyPredictive ScoreNeurological Disorder	2015	51
Therapeutic efficacy and adverse effects of adrenocorticotropic hormone therapy in west syndrome: Differences in dosage of adrenocorticotropic hormone, onset of age, and cause Shin‐ichiro Hamano, Shintaro Yamashita, Manabu Tanaka, The Journal of Pediatrics Adrenal GlandWest SyndromeAdverse EffectsAdrenocorticotropic HormoneAdrenal Disease	2006	49
The axonal damage marker tau protein in the cerebrospinal fluid is increased in patients with acute encephalopathy with biphasic seizures and late reduced diffusion Naoyuki Tanuma, Rie Miyata, Satoko Kumada, Brain and Development Neurodegenerative DiseasesNeurophysiologyCerebrospinal FluidNeurological DisorderBiphasic Seizures	2009	45
The spectrum of <i>ZEB2</i> mutations causing the Mowat–Wilson syndrome in Japanese populations Yasukazu Yamada, Noriko Nomura, Kenichiro Yamada, American Journal of Medical Genetics Part A	2014	45

Page 1